Guatemala Medical Device Registration Roadmap in Ten Steps

1. Key takeaways

The complete market-access chain in Guatemala can be broken down into ten steps: product qualification, checking the exclusion gate, selecting the applicable standard, determining the class, confirming the registration entity, assembling the dossier, paying the official fee, submitting form F-AS-f-08, handling the review and, where required, LNS testing, and finally receiving the registration certificate and starting post-market obligations. An error in any of the first four steps forces rework of everything that follows. The registration certificate is valid for 5 years (Article 8 of NT-37), and on expiry it must be renewed under Article 9. Read as a whole, the roadmap shows that most of the value of good project management in Guatemala sits in the early steps, where the choices are cheap to make and expensive to undo. Each of the ten steps also feeds the next: the qualification and exclusion results justify the standard chosen, the standard determines the class, and the class in turn fixes the testing, the samples and the timetable for everything that follows.

2. Legal basis

Each step of the roadmap rests on a specific provision, set out below in the order of execution.

3. Expert insights

Insight one: the entity comes before the documents. Article 5.1.13 of NT-37 requires a copy of the sanitary licence of the registration entity, and Article 5.1.7 requires a certified copy of the letter of authorisation from the manufacturer. Until the entity is settled, these two items cannot be issued and the dossier cannot take shape. Sequencing the entity decision early is therefore not an administrative preference but a structural prerequisite, since the same entity designation also drives who signs the submission and who holds the post-market duties.

Insight two: the official fee receipt is the first document item. Article 5.1.1 lists the payment receipt as the first item of the document list and states that the fee already includes sanitary oversight (vigilancia sanitaria). This shows the official fee is not merely an acceptance charge but brings the post-market surveillance cost forward into the registration itself. Budget owners should therefore read the fee schedule as covering the full compliance cycle rather than a single filing event.

Insight three: testing continues to bind after the review. The note to Annex 2 provides that for products requiring testing, if the LNS conclusion is nonconforming, the registration is automatically cancelled and the responsible party must withdraw the product from the market within 15 days. Receiving the certificate therefore does not discharge the risk; sample consistency and the stability of production batches must be managed continuously. The binding force of the laboratory conclusion is exactly why the earlier chapters recommend keeping the testing workstream separate from the document review workstream.

Insight four: renewal cannot run past its term. The final paragraph of Article 9 states that where a registration has already expired, renewal is no longer available and a new application must be made under Article 5. The renewal schedule must reserve DRCPFA processing time and cannot be left to the expiry day itself. A lapsed registration also interrupts the legal basis for import and sale, so the calendar for renewal belongs to the same project plan as the original registration, not to a separate list.

Insight five: post-market obligations start from registration, not afterwards. Article 32 of 712-99 requires the registration holder to keep the sanitary file continuously updated, and NT-36 v6-2023 governs market surveillance. Treating post-market matters as something to consider after the certificate arrives breaks the chain at the first change or surveillance inspection. The change ledger, the renewal calendar and the surveillance contact points are set up on day one, not when the first event forces them.

4. Practical recommendations

• Run the project on a ten-step Gantt chart, with an independent review gate set at each of the first four steps.
• Keep the registration entity arrangement separate from the commercial channels, so later transfer disputes are avoided.
• Calculate the official fee on the basis officially published at the time of acceptance, and file the payment receipt as the first item of the dossier.
• For Class II–IV projects, schedule LNS testing as a separate workstream and prepare sealed samples.
• Reserve processing time in the renewal schedule so the registration does not lapse into a new application.
• Establish the change and file-update ledger on the very day the registration is issued.

5. Verification checklist

• □ The ten-step milestones are scheduled in the project plan
• □ Review gates are set for the first four steps (qualification, exclusion, standard selection, classification)
• □ The registration entity is confirmed and independent of the commercial channels
• □ The payment receipt is filed as the first item of the dossier
• □ Class II–IV testing and sealed samples are scheduled
• □ The renewal schedule reserves processing time
• □ The change and file-update ledger is established

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com